In this study, we performed a systematic review and meta‐analysis of the updated literature to re‐assess whether angiotensin converting enzyme inhibitors (ACE‐I) reduced the risk of pneumonia in adults older than 18 years. The gene discussed is ACE; the disease is susceptibility to pneumonia measurement.